TY - JOUR
T1 - 1-Benzhydryl-3-phenylurea and 1-benzhydryl-3-phenylthiourea derivatives
T2 - New templates among the CB1 cannabinoid receptor inverse agonists
AU - Muccioli, Giulio G.
AU - Wouters, Johan
AU - Scriba, Gerhard K E
AU - Poppitz, Wolfgang
AU - Poupaert, Jacques H.
AU - Lambert, Didier M.
PY - 2005/11/17
Y1 - 2005/11/17
N2 - New 1-benzhydryl-3-phenylurea derivatives and their 1-benzhydryl-3- phenylthiourea isosteres were synthesized and evaluated for their human CB 1 and CB2 cannabinoid receptor affinity. These compounds proved to be selective CB1 cannabinoid receptor ligands, acting as inverse agonists in a [35S]-GTPγS assay. The affinity of 3,5,5′-triphenylimidazolidine-2,4-dione and 3,5,5′-triphenyl-2- thioxoimidazolidin-4-one derivatives, possessing the 1-benzhydryl-3-phenylurea and 1-benzhydryl-3-phenylthiourea moiety, respectively, was also evaluated. In conclusion, the 1-benzhydryl-3-phenylurea scaffold seems to be a new interesting template of CB1 cannabinoid receptor inverse agonists.
AB - New 1-benzhydryl-3-phenylurea derivatives and their 1-benzhydryl-3- phenylthiourea isosteres were synthesized and evaluated for their human CB 1 and CB2 cannabinoid receptor affinity. These compounds proved to be selective CB1 cannabinoid receptor ligands, acting as inverse agonists in a [35S]-GTPγS assay. The affinity of 3,5,5′-triphenylimidazolidine-2,4-dione and 3,5,5′-triphenyl-2- thioxoimidazolidin-4-one derivatives, possessing the 1-benzhydryl-3-phenylurea and 1-benzhydryl-3-phenylthiourea moiety, respectively, was also evaluated. In conclusion, the 1-benzhydryl-3-phenylurea scaffold seems to be a new interesting template of CB1 cannabinoid receptor inverse agonists.
UR - http://www.scopus.com/inward/record.url?scp=28544451559&partnerID=8YFLogxK
U2 - 10.1021/jm0503906
DO - 10.1021/jm0503906
M3 - Article
C2 - 16279809
AN - SCOPUS:28544451559
SN - 0022-2623
VL - 48
SP - 7486
EP - 7490
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 23
ER -